Our results are consistent with this hypothesis, since A2M could play a role in inhibiting plasmin (inhibiting fibrinolysis), thus contributing to the hypercoagulable state characteristic of the disease, and vitronectin could be related to the increase in fibrosis and endothelial dysfunction. The gene discussed is VTN; the disease is endothelial dysfunction.